Table 3

Meta-regression model with the mean difference (%) in desphopho-uncarboxyated matrix Gla protein as the dependent variable

VariableCoefficient95% CIP valuesTau2
Unadjusted
No covariate 451.1
 Year of publication6.39−1.24 to 14.020.10232.7
 Duration of follow-up−0.82−1.86 to 0.220.12185.3
 Vitamin K form23.64−13.33 to 60.600.21278.0
 Dose−0.01−0.04 to 0.020.42366.1
Adjusted
Model 1
 Duration of follow-up−0.82−1.58 to 0.050.0466.7
 Vitamin K form19.72−6.97 to 46.420.15
Model 2
 Duration of follow-up−1.03−1.45 to 0.61<0.0010.0
 Dose−0.02−0.04 to 0.000.045
Model 3
 Duration of follow-up−0.51−1.67 to 0.650.39195.1
 Year of publication5.01−2.99 to 13.000.22
Model 4
 Duration of follow-up−0.70−2.23 to 0.830.37339.5
 Dose−0.01−0.06 to 0.040.68
 Vitamin K form6.74−62.58 to 76.050.85
Model 5
 Duration of follow-up−0.81−1.31 to 0.310.0020.74
 Dose−0.02−0.04 to 0.0010.04
 Year of publication4.60−0.93 to 10.130.10